How Europe is building a sweeping system to study medication safety in pregnant and lactating women

More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
Source: FRED DUFOUR/AFP/Getty Images

Drug companies, politicians, hospitals, doctors, and patients all agree that there isn’t nearly enough information about whether a given medicine is safe for pregnant and breastfeeding women to use or whether it will work.

A sweeping new effort in Europe aims to change that by bringing all of those groups together to address a public health issue they say demands urgent attention.

The project, dubbed ConcePTION, is a $32 million effort from the Innovative Medicines Initiative, a public-private partnership between the drug industry and the European Commission, the executive branch of the European Union. There are more than 200 researchers and 88 organizations involved in ConcePTION, which is being

You're reading a preview, sign up to read more.

More from STAT

STAT1 min read
STAT+: Pharmalittle: Teva Reaches $4.25 Billion Deal Over Its Role In Opioid Crisis; Feds Probe Cassava Over Alzheimer’s Drug Data
Teva Pharmaceutical reached a national settlement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.
STAT1 min read
STAT+: Pharmalittle: White House To Launch Effort For New Generation Of Covid Shots; Indian Court Rejects Bail Pleas In Biocon Bribery Case
The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants.
STAT1 min read
STAT+: Pharmalittle: FDA Will Review Biogen ALS Drug Despite Inconclusive Results; Shkreli Launches Drug-discovery Software Company
The FDA agreed to review a Biogen treatment for a rare, genetically defined form of ALS, even though a clinical trial failed to show a definitive benefit.